Skip to main content
Fig. 5 | Acta Neuropathologica Communications

Fig. 5

From: NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors

Fig. 5

Summary of the radiological characteristics and treatment timelines for patients receiving TRK inhibitor therapy (IHG: Infant-type hemispheric glioma, DLGG: Diffuse low-grade glioma, DHGG: Diffuse high-grade glioma, GBM: Glioblastoma, IDH-Wild-type, OP: Operation, SD: Stable disease, PD: Progressive disease, NET: No evidence of tumour, aPBSCT: autologous peripheral blood stem cell transplantation; Carbo, carboplatin, Thio, thioflavin #3)

Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us